Tag: Teva TEV-749 Phase 3 trial success
Teva’s TEV-749 Shows Promising Results in Phase 3 Schizophrenia Study
Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries, recently shared positive results from the Phase 3 SOLARIS trial of TEV-‘749 (olanzapine) for treating...
BREAKING NEWS
The Average Personal Debt Held by Australians: A Detailed Analysis
The personal debt landscape in Australia has been unveiled by Canstar, shedding light on the financial burdens carried by the average Aussie. Credit card...
